The Scientific Research and Development team at Hyku Biosciences is dedicated to pioneering innovative approaches for precise covalent targeting of disease-related proteins. Comprised of experts in biology, chemistry, and proteomics, the team focuses on developing and validating cutting-edge therapeutic strategies that aim to transform treatment paradigms and enhance patient outcomes in various diseases, particularly cancer.
View all